Sharon Dell Verified Researcher

Default group image mini 35bd0985f7c7e821b0d6c6f0188d5a7a3d7780a4d042b1e08d59d06486caa3b2 The Hospital for Sick Children
All 593493ee10024290301392dccff9215c294fe39ab69c908eb53eb42fae8de5ae Epidemiology   All 593493ee10024290301392dccff9215c294fe39ab69c908eb53eb42fae8de5ae Genetics  

Dr. Sharon Dell, BEng, MD, FRCPC is a pediatric respirologist (A.K.A. pulmonologist) and senior associate scientist at the Hospital for Sick Children in Toronto, Canada. She is also a Full Professor in the Department of Pediatrics and past director (2010-2015) of the Clinical Epidemiology and Health Care Research MSc/PhD graduate program in the Institute of Health Policy Management & Evaluation at the University of Toronto. Dr. Dell divides her time between conducting research and clinical care, leading sub-specialty clinics in primary ciliary dyskinesia (PCD), Children’s Interstitial Lung Disease (ChILD) (including pulmonary vasculitis) and severe asthma. Dr Dell is an active member of multiple professional societies and has many international research collaborations in pediatric rare lung disease. She has participated in international clinical guideline development for rare pediatric diseases (eg. American Thoracic Society (ATS) ChILD in infancy and PCD statements; European Respiratory Society Taskforce for PCD diagnosis) and is the incoming ATS Pediatric Scientific Program Committee chair. Within Canada, she is a member of the Ontario Thoracic Society (past Chair of Provider Education Program, member of OTS executive committee) and Canadian Thoracic Society (CTS Asthma Clinical Assembly expert panel and asthma guidelines committee member). She recently (2016) completed a six month visiting scholar appointment at the University of Sydney in New South Wales, Australia. Research: Dr. Dell’s research program focuses on evaluating health outcomes, risk factors, genotype/phenotype correlations and diagnostic tests in children with lung disease, including asthma and rare orphan lung diseases. Dr. Dell participates in several North American and European multi-center research collaborations, including the NIH funded Genetic Diseases of Mucociliary Clearance Consortium, the Children’s Interstitial Lung Disease (ChILD) Network and the BEAT-PCD COST Action BMI1407.